首站-论文投稿智能助手
典型文献
Designing nanocarriers to overcome the limitations in conventional drug administration for Parkinson's disease
文献摘要:
Neurodegenerative diseases (NDs) have become one of the leading causes of death and disability worldwide, and cause enormous pain and suffering for both patients and their families. Some of the most common NDs include Alzheimer's disease, Parkinson's disease (PD) and Huntington's disease, among others (Feng, 2020). PD is a widespread neurodegenerative disease that affects more than 10 million people worldwide (No author listed, 2021). The direct cause of the disease is unknown, but it is characterized by the selective degeneration of dopaminergic neurons in the midbrain in the substantia nigra. This leads to the depletion of dopamine (3,4-dihydroxyphenethylamine, DA) in the striatum of patients, in addition to the existence of abnormal α-synuclein in nerve cells and the development of toxic protein aggregates in neurons called Lewy bodies, which causes muscle stiffness, slowness of movements and tremors. It is believed that a combination of genetic and environmental factors may be the cause of PD, but the exact reason for the disease is not yet fully understood.
文献关键词:
作者姓名:
Rafael A.García-Mu?oz;Joseph McConnell;Victoria Morales;Raul Sanz
作者机构:
Department of Chemical and Environmental Technology,Rey Juan Carlos University,Madrid,Spain;Department of Chemical&Process Engineering,University of Strathclyde,Glasgow,UK
引用格式:
[1]Rafael A.García-Mu?oz;Joseph McConnell;Victoria Morales;Raul Sanz-.Designing nanocarriers to overcome the limitations in conventional drug administration for Parkinson's disease)[J].中国神经再生研究(英文版),2022(08):1743-1744
A类:
dihydroxyphenethylamine,slowness
B类:
Designing,nanocarriers,overcome,limitations,conventional,drug,administration,Parkinson,Neurodegenerative,diseases,NDs,have,become,one,leading,causes,death,disability,worldwide,enormous,pain,suffering,both,patients,their,families,Some,most,common,include,Alzheimer,Huntington,among,others,Feng,widespread,neurodegenerative,that,affects,more,than,million,people,No,author,listed,direct,unknown,but,characterized,by,selective,degeneration,dopaminergic,neurons,midbrain,substantia,nigra,This,leads,depletion,DA,striatum,addition,existence,abnormal,synuclein,nerve,cells,development,toxic,protein,aggregates,called,Lewy,bodies,which,muscle,stiffness,movements,tremors,It,believed,combination,genetic,environmental,factors,may,exact,reason,not,yet,fully,understood
AB值:
0.67627
相似文献
CHCHD2 maintains mitochondrial contact site and cristae organizing system stability and protects against mitochondrial dysfunction in an experimental model of Parkinson’s disease
Lu Lin;Mao Hengxu;Zhou Miaomiao;Lin Yuwan;Dai Wei;Qiu Jiewen;Xiao Yousheng;Mo Mingshu;Zhu Xiaoqin;Wu Zhuohua;Pei Zhong;Guo Wenyuan;Xu Pingyi;Chen Xiang-Department of Neurology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510120, China;Department of Neurology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, China;School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, Guangdong 511436, China;Department of Neurology, National Key Clinical Department and Key Discipline of Neurology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong 510080, China
Alzheimer's disease:current status and perspective
Wenying Liu;Serge Gauthier;Jianping Jia-Innovation Center for Neurological Disorders and Department of Neurology,Xuanwu Hospital,Capital Medical University,National Clinical Research Center for Geriatric Diseases,Beijing 100053,China;Departments of Neurology and Neurosurgery,and Department of Psychiatry,McGill Centre for Studies in Aging,McGill University,Montreal H4H1R3,Canada;Beijing Key Laboratory of Geriatric Cognitive Disorders,Beijing 100053,China;Clinical Center for Neurodegenerative Disease and Memory Impairment,Capital Medical University,Beijing 100053,China;Center of Alzheimer's Disease,Beijing Institute of Brain Disorders,Collaborative Innovation Center for Brain Disorders,Capital Medical University,Beijing 100053,China;Key Laboratory of Neurodegenerative Diseases,Ministry of Education,Beijing 100053,China
Structural basis of the activation of metabotropic glutamate receptor 3
Wei Fang;Fan Yang;Chanjuan Xu;Shenglong Ling;Li Lin;Yingxin Zhou;Wenjing Sun;Xiaomei Wang;Peng Liu;Philippe Rondard;Pan Shi;Jean-Philippe Pin;Changlin Tian;Jianfeng Liu-The First Affiliated Hospital of USTC,School of Life Sciences,Division of Life Sciences and Medicine,Joint Center for Biological Analytical Chemistry,Anhui Engineering Laboratory of Peptide Drug,Anhui Laboratory of Advanced Photonic Science and Technology,University of Science and Technology of China,Hefei,Anhui,China;Key Laboratory of Molecular Biophysics of MOE,International Research Center for Sensory Biology and Technology of MOST,College of Life Science and Technology,Huazhong University of Science and Technology(HUST),Wuhan,Hubei,China;Bioland Laboratory,Guangzhou Regenerative Medicine and Health Guangdong Laboratory,Guangzhou,Guangdong,China;Institut de Génomique Fonctionnelle(IGF),Université de Montpellier,CNRS,INSERM,Montpellier,France
Targeting a novel inducible GPX4 alternative isoform to alleviate ferroptosis and treat metabolic-associated fatty liver disease
Jie Tong;Dongjie Li;Hongbo Meng;Diyang Sun;Xiuting Lan;Min Ni;Jiawei Ma;Feiyan Zeng;Sijia Sun;Jiangtao Fu;Guoqiang Li;Qingxin Ji;Guoyan Zhang;Qirui Shen;Yuanyuan Wang;Jiahui Zhu;Yi Zhao;Xujie Wang;Yi Liu;Shenxi Ouyang;Chunquan Sheng;Fuming Shen;Pei Wang-Department of Pharmacy,Shanghai Tenth People's Hospital,Tongji University School of Medicine,Shanghai 200072,China;Institute of Nuclear Medicine,Tongji University School of Medicine,Shanghai 200072,China;Department of General Surgery,Shanghai Tenth People's Hospital,Tongji University School of Medicine,Shanghai 200072,China;Department of Pharmacology,School of Pharmacy,Naval Medical University/Second Military Medical University,Shanghai 200433,China;Department of Pharmacy,Shanghai Fourth People's Hospital,Tongji University School of Medicine,Shanghai 200081,China;Shanghai Key Laboratory of Regulatory Biology,Institute of Biomedical Sciences and School of Life Sciences,East China Normal University,Shanghai 200241,China;Chemical Biology Research Center School of Pharmaceutical Sciences,Wenzhou Medical University,Wenzhou 325000,China;Department of Medicinal Chemistry,School of Pharmacy,Naval Medical University/Second Military Medical University,Shanghai 200433,China
Corynoxine B derivative CB6 prevents Parkinsonian toxicity in mice by inducing PIK3C3 complex-dependent autophagy
Zhou Zhu;Liang-feng Liu;Cheng-fu Su;Jia Liu;Benjamin Chun-Kit Tong;Ashok lyaswamy;Senthilkumar Krishnamoorthi;Sravan Gopalkrishnashetty Sreenivasmurthy;Xin-jie Guan;Yu-xuan Kan;Wen-jian Xie;Chen-liang Zhao;King-ho Cheung;Jia-hong Lu;Jie-qiong Tan;Hong-jie Zhang;Ju-xian Song;Min Li-Mr.&Mrs.Ko Chi-Ming Centre for Parkinson's Disease Research,School of Chinese Medicine,Hong Kong Baptist University,Hong Kong,SAR,China;School of Chinese Medicine,Hong Kong Baptist University,Hong Kong,SAR,China;institute for Research and Continuing Education,Hong Kong Baptist University,Shenzhen 518057,China;Limin Pharmaceutical Factory,Livzon Group Limited,Shaoguan 512028,China;State Key Laboratory of Quality Research in Chinese Medicine,Institute of Chinese Medical Sciences,University of Macau,Macau,SAR,China;Center for Medical Genetics and Hunan Key Laboratory of Animal Model for Human Diseases,School of Life Sciences,Central South University,Changsha 410078,China;Medical College of Acupuncture-Moxibustion and Rehabilitation,Guangzhou University of Chinese Medicine,Guangzhou 510006,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。